CD40 and Its Ligand in Host Defense
Open Access
- 1 May 1996
- Vol. 4 (5) , 415-419
- https://doi.org/10.1016/s1074-7613(00)80408-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania majorImmunity, 1996
- Protective Role of CD40 in Leishmania major Infection at Two Distinct Phases of Cell-Mediated ImmunityPublished by Elsevier ,1996
- Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis InfectionImmunity, 1996
- Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interactionEuropean Journal of Immunology, 1995
- Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responsesEuropean Journal of Immunology, 1995
- Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1European Journal of Immunology, 1995
- The role of CD40 in the regulation of humoral and cell-mediated immunityImmunology Today, 1994
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994
- Mice deficient for the CD40 ligandPublished by Elsevier ,1994
- Germinal centres in T-cell-dependent antibody responsesImmunology Today, 1992